Orchard Therapeutics plc Quarterly Earnings Per Share, Basic in USD/shares from Q2 2021 to Q3 2023

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Orchard Therapeutics plc quarterly/annual Earnings Per Share, Basic history and growth rate from Q2 2021 to Q3 2023.
  • Orchard Therapeutics plc Earnings Per Share, Basic for the quarter ending September 30, 2023 was -0.15 USD/shares, a 59.5% increase year-over-year.
  • Orchard Therapeutics plc Earnings Per Share, Basic for the twelve months ending September 30, 2023 was -0.4 USD/shares.
  • Orchard Therapeutics plc annual Earnings Per Share, Basic for 2022 was -1.18 USD/shares, a 0.86% decline from 2021.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 $0 $0 +$0.22 +59.5% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 -$1 $0 +$0.33 +82.5% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-10
Q1 2023 -$1 $0 +$0.23 +65.7% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-15
Q4 2022 -$1 $0 Oct 1, 2022 Dec 31, 2022 10-K 2023-03-14
Q3 2022 $0 $0 -27.6% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $0 $0 -37.9% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $0 Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q3 2021 $0 Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $0 Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.